Honestly IMO IVX deserve to be at a higher market cap for what they have achieved till date. There are plently of other biotechs in similar position and at much higher market cap.
We now have 2 very credible partners coming on board - Hudson and now Peter Maccullan.
We will be starting multiple different cancer trials at the same time next year. Multiple irons in the fire.
Fully funded and cap raise not required.
Deserve to be better
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $32.12M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $4.5K | 1.1M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 10297949 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5917812 | 26 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IVX (ASX) Chart |